Status:
COMPLETED
Vitamin D as a Key Player in Rheumatoid Arthritis
Lead Sponsor:
Assiut University
Conditions:
the Immunomodulatory Effect
Eligibility:
All Genders
20-70 years
Phase:
PHASE3
Brief Summary
Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of joints linked to autoimmunity. Vitamin D was found to modulate cell growth, function of immune cells and anti-inflammatory ...
Detailed Description
Rheumatoid arthritis (RA) is a systemic, chronic and inflammatory disease of joints linked to autoimmunity. Vitamin D was found to modulate cell growth, function of immune cells and anti-inflammatory ...
Eligibility Criteria
Inclusion
- RA patients
Exclusion
- Patients with inflammatory bowel disease patients with any other autoimmune diseases
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04344405
Start Date
June 1 2019
End Date
June 1 2021
Last Update
June 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manal Hassanien
Asyut, Assuit, Egypt, 71111